
Sign up to save your podcasts
Or


We discuss the latest information on phase 2 trials of gene therapy for x-linked retinitis pigmentosa with Dr. Nadia Waheed, Chief Medical Officer of Beacon Therapeutics and Associate Professor of Ophthalmology at the New England Eye Center, Tufts University School of Medicine.
By Retina Synthesis4.5
88 ratings
We discuss the latest information on phase 2 trials of gene therapy for x-linked retinitis pigmentosa with Dr. Nadia Waheed, Chief Medical Officer of Beacon Therapeutics and Associate Professor of Ophthalmology at the New England Eye Center, Tufts University School of Medicine.

43 Listeners

18 Listeners

97 Listeners

5 Listeners

6,062 Listeners

4 Listeners

21 Listeners

10 Listeners

50 Listeners

11 Listeners

19 Listeners

0 Listeners

1 Listeners

18 Listeners

0 Listeners